tomeko

3-methylglutaconic aciduria type 9

Just diagnosed with 3-methylglutaconic aciduria type 9?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees 3-methylglutaconic aciduria type 9, look for clinical trials, and connect with others living with it — all in one place.

Open the full 3-methylglutaconic aciduria type 9 hub →

Overview

3-methylglutaconic aciduria type 9 is a rare condition. Also known as 3-methylglutaconic aciduria-epilepsy-spasticity-severe intellectual disability syndrome, MGA9. Tomeko brings together the specialists, research, clinical trials, treatments and community for 3-methylglutaconic aciduria type 9 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:505216 · OMIM 617698 · ICD-10 E71.1 · GARD 0017940

Find care for 3-methylglutaconic aciduria type 9

Authoritative references for 3-methylglutaconic aciduria type 9

Common questions

I was just diagnosed with 3-methylglutaconic aciduria type 9 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees 3-methylglutaconic aciduria type 9, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for 3-methylglutaconic aciduria type 9?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat 3-methylglutaconic aciduria type 9, filtered to your area.

Are there clinical trials for 3-methylglutaconic aciduria type 9?

Tomeko shows live, recruiting studies for 3-methylglutaconic aciduria type 9 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com